GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 117 filers reported holding GENERATION BIO CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $577,084 | -31.1% | 152,265 | 0.0% | 0.00% | – |
| Q2 2023 | $837,458 | +27.5% | 152,265 | -0.3% | 0.00% | – |
| Q1 2023 | $656,670 | +12.4% | 152,714 | 0.0% | 0.00% | – |
| Q4 2022 | $584,232 | -24.9% | 152,714 | +0.5% | 0.00% | -100.0% |
| Q3 2022 | $777,967 | -22.9% | 152,011 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $1,008,852 | -8.3% | 152,574 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,099,646 | +562.4% | 152,529 | +555.8% | 0.00% | – |
| Q4 2021 | $166,000 | -70.5% | 23,259 | +3.6% | 0.00% | – |
| Q3 2021 | $563,000 | -13.3% | 22,456 | -6.9% | 0.00% | -100.0% |
| Q2 2021 | $649,000 | +3.5% | 24,121 | +9.5% | 0.00% | 0.0% |
| Q1 2021 | $627,000 | +207.4% | 22,020 | +206.7% | 0.00% | – |
| Q4 2020 | $204,000 | +0.5% | 7,179 | +9.5% | 0.00% | – |
| Q3 2020 | $203,000 | – | 6,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
| GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
| HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
| Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
| PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
| Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
| Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
| BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |